Cargando…
Representation matters: a call for inclusivity and equity in heart failure clinical trials
The burden of heart failure remains substantial worldwide, and heart failure with reduced ejection fraction (HFrEF) affects approximately half of this population. Despite this global prevalence of HFrEF, the majority of contemporary clinical trials in HFrEF have underenrolled individuals from minori...
Autores principales: | Reza, Nosheen, Nayak, Aditi, Lewsey, Sabra C, DeFilippis, Ersilia M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762878/ https://www.ncbi.nlm.nih.gov/pubmed/36545232 http://dx.doi.org/10.1093/eurheartjsupp/suac115 |
Ejemplares similares
-
Dear colleagues: enough with the men-only author panels
por: Van Spall, Harriette G C, et al.
Publicado: (2022) -
Aiming at harmony. Comparing and contrasting International HFrEF Guidelines
por: Tomasoni, Daniela, et al.
Publicado: (2022) -
Time for change
por: Zieroth, Shelley, et al.
Publicado: (2022) -
The four pillars of HFrEF therapy: is it time to treat heart failure regardless of ejection fraction?
por: Docherty, Kieran F, et al.
Publicado: (2022) -
A rationale for dedicated trials of combination therapy in heart failure
por: Blumer, Vanessa, et al.
Publicado: (2022)